<?xml version="1.0" encoding="UTF-8"?>
<p>Canyon binders are members of the immunoglobulin superfamily including: (i) ICAM-1 used by HRV and CVA (Greve et al., 
 <xref rid="B39" ref-type="bibr">1989</xref>; Staunton et al., 
 <xref rid="B121" ref-type="bibr">1989</xref>; Tomassini et al., 
 <xref rid="B128" ref-type="bibr">1989</xref>; Kolatkar et al., 
 <xref rid="B52" ref-type="bibr">1999</xref>; Xiao et al., 
 <xref rid="B141" ref-type="bibr">2001</xref>; Baggen et al., 
 <xref rid="B4" ref-type="bibr">2018</xref>), (ii) the PV receptor (PVR) (Mendelsohn et al., 
 <xref rid="B77" ref-type="bibr">1989</xref>; He et al., 
 <xref rid="B40" ref-type="bibr">2000</xref>; Strauss et al., 
 <xref rid="B123" ref-type="bibr">2015</xref>), (iii) the coxsackie and adenovirus receptor (CAR) used by CVBs (Bergelson, 
 <xref rid="B7" ref-type="bibr">1997</xref>; He et al., 
 <xref rid="B41" ref-type="bibr">2001</xref>; Organtini et al., 
 <xref rid="B91" ref-type="bibr">2014</xref>; Lee et al., 
 <xref rid="B59" ref-type="bibr">2016</xref>), (iv) α
 <sub>v</sub>β
 <sub>3</sub> and α
 <sub>v</sub>β
 <sub>6</sub> integrin used by some CVAs (Roivainen et al., 
 <xref rid="B105" ref-type="bibr">1994</xref>; Williams et al., 
 <xref rid="B139" ref-type="bibr">2004</xref>; Shakeel et al., 
 <xref rid="B113" ref-type="bibr">2013</xref>), and (v) the α2 subunit of VLA-2 used by E1 and E8 (Bergelson et al., 
 <xref rid="B10" ref-type="bibr">1992</xref>; Xing et al., 
 <xref rid="B146" ref-type="bibr">2004</xref>). Canyon binders' apical domain engages in the binding into the canyon, triggering conformational changes essential for infection, leading to the altered-particle (A-particle) conformational state (Greve et al., 
 <xref rid="B39" ref-type="bibr">1989</xref>; Xing et al., 
 <xref rid="B146" ref-type="bibr">2004</xref>; Xiao et al., 
 <xref rid="B142" ref-type="bibr">2005</xref>; Shakeel et al., 
 <xref rid="B113" ref-type="bibr">2013</xref>; Organtini et al., 
 <xref rid="B91" ref-type="bibr">2014</xref>; Strauss et al., 
 <xref rid="B123" ref-type="bibr">2015</xref>). These changes have been observed to depend on the number of binding events that stimulate the viral particle (Lee et al., 
 <xref rid="B59" ref-type="bibr">2016</xref>). Engagement of several receptors is known to bring the viral 5-fold vertex close to the cell membrane (Bubeck et al., 
 <xref rid="B13" ref-type="bibr">2005</xref>).
</p>
